An Oral Formulation of YK-4-279: Preclinical Efficacy and Acquired Resistance Patterns in Ewing Sarcoma
暂无分享,去创建一个
J. Ludwig | R. Aiyer | S. Lamhamedi-Cherradi | V. Ramamoorthy | Brian A. Menegaz | K. Culotta | A. Buford | J. O'dorisio | Rebecca L. Maywald | D. Doolittle